The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Pati... von Kaufman-Janette, Joely, Avelar, Rui L, Biesman, Brian S, Draelos, Zoe Diana, Gross, John E, Jones, Derek H, Lupo, Mary P, Maas, Corey S, Schlessinger, Joel, Shamban, Ava Teresa, Sundaram, Hema, Weinkle, Susan H, Young, Vernon L

Volltext

The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Pat... von Lorenc, Z Paul, Adelglass, Jeffrey M, Avelar, Rui L, Baumann, Leslie, Beer, Kenneth R, Cohen, Joel L, Cox, Sue Ellen, Dayan, Steven H, Dover, Jeffrey S, Downie, Jeanine B, Draelos, Zoe Diana, Goldman, Mitchel P, Gross, John E, Joseph, John H, Kaufman-Janette, Joely, Moy, Ronald L, Nestor, Mark, Schlessinger, Joel, Smith, Stacy R, Weiss, Robert A

Volltext

Collagenase Clostridium Histolyticum-aaes for Treatment of Cellulite: A Pooled Analysis of Two Phase-3 Trials von Bass, Lawrence S., Kaufman-Janette, Joely, Joseph, John H., Kaminer, Michael S., Clark, James, Fabi, Sabrina G., Gold, Michael H., Katz, Bruce E., Peddy, Kappa, Schlessinger, Joel, Young, V. Leroy, Hurley, David, McLane, Michael P., Vijayan, Saji, Liu, Genzhou, Davis, Matthew W., Goldman, Mitchel P.

Volltext

Commentary on Microcannula Injection of Large Gel Particle Hyaluronic Acid for Cheek Augmentation and the Correction of Age-Related Midface Contour Deficiencies von Schlessinger, Daniel I., Schlessinger, Joel

Volltext

7th Annual Cosmetic Surgery Forum 2015 von Schlessinger, Joel

Volltext

DaxibotulinumtoxinA for Injection has a prolonged duration of response in the treatment of glabellar lines: Pooled data from two multicenter, randomized, double-blind, placebo-cont... von Bertucci, Vince, Solish, Nowell, Kaufman-Janette, Joely, Yoelin, Steve, Shamban, Ava, Schlessinger, Joel, Snyder, Daniel, Gallagher, Conor, Liu, Yan, Shears, Gill, Rubio, Roman G.

Volltext

33499 Subject-relevant outcomes of on-label 50U abobotulinumtoxinA treatment for moderate-to-severe glabellar lines across three individual trials von Glaser, Dee Anna, Cox, Sue Ellen, Moradi, Amir, Dayan, Steven, Jacob, Carolyn, Schlessinger, Joel, Joseph, John

Volltext

Millennial Subject Satisfaction With Two Treatments of AbobotulinumtoxinA Per Year von Cohen, Joel L., Jacob, Carolyn, Schlessinger, Joel, Meckfessel, Matthew, Coquis-Knezek, Sarah

Volltext

Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1)... von Schlessinger, Joel, Shepard, Julie S., Gower, Richard, Su, John C., Lynde, Charles, Cha, Amy, Ports, William C., Purohit, Vivek, Takiya, Liza, Werth, John L., Zang, Chuanbo, Vlahos, Bonnie

Volltext

Efficacy and Safety of Ruxolitinib Cream Among Children With Atopic Dermatitis Aged 2 to 6 Years and 7 to <12 Years: Results from a Phase 3 Double-Blind Vehicle-Controlled Study von Soong, Weily, Zaenglein, Andrea, Tollefson, Megha, Simpson, Eric, Devani, Alim, Joyce, Joel, Forsha, Douglass, Schlessinger, Joel, Kallender, Howard, Angel, Brett, Li, Qian, Paller, Amy

Volltext

53083 Efficacy and safety of a novel formulation liquid botulinum toxin, RelabotulinumtoxinA, when used for combination treatment of glabellar and lateral canthal lines von Schlessinger, Joel, Joseph, John, Shamban, Ava, Lorenc, Z. Paul, Weiss, Robert, Valley, Hunt, Bertucci, Vince, Baumann, Leslie, Nestor, Mark S., Prather, Heidi B., Jones, Derek, Kazin, Rebecca

Volltext

Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis von Blauvelt, Andrew, Kempers, Steven, Lain, Edward, Schlesinger, Todd, Tyring, Stephen, Forman, Seth, Ablon, Glynis, Martin, George, Wang, Hui, Cutler, David L, Fang, Jane, Kwan, Min-Fun R

Volltext

A Multicenter Study to Evaluate Subject Satisfaction With Two Treatments of AbobotulinumtoxinA a Year in the Glabellar Lines von Schlessinger, Joel, Cohen, Joel L., Shamban, Ava, Jacob, Carolyn, Karimi, Kian, Maas, Corey, Lane, Vanessa, Coquis-Knezek, Sarah, Meckfessel, Matthew

Volltext

A Review of Current Data on Duration of Effect in Glabellar Lines After Treatment With AbobotulinumtoxinA 50 U von Cohen, Joel L, Cox, Sue Ellen, Glaser, Dee Anna, Moradi, Amir, Dayan, Steven, Jacob, Carolyn, Schlessinger, Joel, Joseph, John, Kaufman-Janette, Joely, El-Qadi, Sami, Persson, Cecilia, Prygova, Inna

Volltext

New Uses of AbobotulinumtoxinA in Aesthetics von Schlessinger, Joel, Gilbert, Erin, Cohen, Joel L, Kaufman, Joely

Volltext

Efficacy and Safety of a New Resilient Hyaluronic Acid Filler in the Correction of Moderate-to-Severe Dynamic Perioral Rhytides: A 52-Week Prospective, Multicenter, Controlled, Ran... von Sundaram, Hema, Shamban, Ava, Schlessinger, Joel, Kaufman-Janette, Joely, Joseph, John H., Lupin, Mark, Draelos, Zoe, Carey, Wayne, Smith, Stacy, Eaton, Laura

Volltext

Subject-Relevant Outcomes of On-Label 50 U AbobotulinumtoxinA Treatment for Moderate-to-Severe Glabellar Lines Across Three Individual Trials von Moradi, Amir, Cox, Sue Ellen, Glaser, Dee Anna, Dayan, Steven, Jacob, Carolyn, Schlessinger, Joel, Joseph, John, Andriopoulos, Bill

Volltext

26993 Efficacy and safety of crisaborole by body region in infants with mild-to-moderate atopic dermatitis von Schlessinger, Joel, Shepard, Julie S., Forsha, Douglass W., Zaenglein, Andrea L., Werth, John L., Zang, Chuanbo, Cha, Amy, Takiya, Liza

Volltext

DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Results from Each of Two Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Studies (SAKURA... von Carruthers, Jean D., Fagien, Steve, Joseph, John H., Humphrey, Shannon D., Biesman, Brian S., Gallagher, Conor J., Liu, Yan, Rubio, Roman G.

Volltext

49439 Effect of Ruxolitinib Cream on Patient-Reported Outcomes (PROs) in Children Aged 2–<12 Years With Atopic Dermatitis (AD): Results From a Randomized, Double-Blind, Vehicle-Con... von Simpson, Eric L., Eichenfield, Lawrence F., Paller, Amy S., Zaenglein, Andrea L., Schlessinger, Joel, Shepard, Julie S., Devani, Alim R., Siri, Dareen D., Sturm, Daniel, Li, Qian, Armstrong, April W.

Volltext